Quantitative estimation of the degree of hepatic macrovesicular steatosis in a disease-free population: A single-center experience in mainland China

Liver Transplantation

Volumn 15, Issue 11, 2009, Pages 1605-1612

  Liu, Zuo Jin ^a,b   Gong, Jian Ping ^b   Yan, Lv Nan ^a  

^a SICHUAN UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CHINA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FATTY LIVER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; NONALCOHOLIC FATTY LIVER; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELIABILITY;

ADULT; BIOPSY; BODY MASS INDEX; CHINA; DISEASE-FREE SURVIVAL; FATTY LIVER; FEMALE; HUMANS; LINEAR MODELS; LIPIDS; LIVER; LIVER TRANSPLANTATION; LIVING DONORS; LOGISTIC MODELS; MALE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 72949116952     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21812     Document Type: Article

References (37)

1. Yan L, Li B, Zeng Y, Wen T, Zhao J, Wang W, et al. Preliminary experience for reducing biliary complication in adult-to-adult living donor liver transplantation using right lobe graft. Hepatol Res 2007;37:305-309. (Pubitemid 46505845)
2. Li F, Yan L, Li B, Zeng Y, Wen T, Xu M, et al. Complications in the right lobe adult living donor: single-center experience in China. Transplant Proc 2007;39:2977-2980. (Pubitemid 350258655)
3. Low G, Wiebe E, Walji AH, Bigam DL. Imaging evaluation of potential donors in living-donor liver transplantation. Clin Radiol 2008;63:136-145.
4. Wen TF, Chen ZY, Yan LN, Li B, Zheng Y, Zhao JC, et al. Measures for increasing the safety of donors in living donor liver transplantation using right lobe grafts. Hepatobiliary Pancreat Dis Int 2007;6:590-595.
5. Angele MK, Rentsch M, Hartl WH, Wittmann B, Graeb C, Jauch KW, et al. Effect of graft steatosis on liver function and organ survival after liver transplantation. Am J Surg 2008;195:214-220.
6. Cho JY, Suh KS, Lee HW, Cho EH, Yang SH, Cho YB, et al. Hepatic steatosis is associated with intrahepatic cholestasis and transient hyperbilirubinemia during regeneration after living donor liver transplantation. Transpl Int 2006;19:807-813.
7. Ferraz-Neto BH, Zurstrassen MP, Hidalgo R, Fonseca LE, Motta TD, Pandullo FL, et al. Donor liver dysfunction: application of a new scoring system to identify the marginal donor. Transplant Proc 2007;39:2516-2518. (Pubitemid 47588364)
8. Kwon CH, Joh JW, Lee KW, Kim SJ, Han YS, Park JW, et al. Safety of donors with fatty liver in liver transplantation. Transplant Proc 2006;38:2106-2107. (Pubitemid 46068561)
9. Lee SW, Park SH, Kim KW, Choi EK, Shin YM, Kim PN, et al. Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index. Radiology 2007;244:479-485.
10. Fishbein M, Castro F, Cheruku S, Jain S, Webb B, Gleason T, et al. Hepatic MRI for fat quantitation: its relationship to fat morphology, diagnosis, and ultrasound. J Clin Gastroenterol 2005;39:619-625. (Pubitemid 41061269)
11. Vuppalanchi R, Cummings OW, Saxena R, Ulbright TM, Martis N, Jones DR, et al. Relationship among histological, radiologic, and biochemical assessments of hepatic steatosis: a study of human liver samples. J Clin Gastroenterol 2007;41:206-210. (Pubitemid 46148664)
12. Cheng YF, Chen CL, Lai CY, Chen TY, Huang TL, Lee TY, et al. Assessment of donor fatty livers for liver transplantation. Transplantation 2001;15:1221-1225. (Pubitemid 32507138)
13. Park SH, Kim PN, Kim KW, Lee SW, Yoon SE, Park SW, et al. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 2006;239:105-112.
14. Limanond P, Raman SS, Lassman C, Sayre J, Ghobrial RM, Busuttil RW, et al. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histological findings. Radiology 2004;230:276-280. (Pubitemid 37549813)
15. Rinella ME, Alonso E, Rao S, Whitington P, Fryer J, Abecassis M, et al. Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Transpl 2001;7:409-414. (Pubitemid 32492578)
16. Rinella ME, Abecassis MM. Liver biopsy in living donors. Liver Transpl 2002;8:1123-1125.
17. Iwasaki M, Takada Y, Hayashi M, Minamiguchi S, Haga H, Maetani Y, et al. Noninvasive evaluation of graft steatosis in living donor liver transplantation. Transplantation 2004;78:1501-1505. (Pubitemid 39552937)
18. de Alwis NM, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol 2008;48:S104-S112.
19. Nadalin S, Malagó M, Valentin-Gamazo C, Testa G, Testa G, Baba HA, et al. Preoperative donor liver biopsy for adult living donor liver transplantation: risks and benefits. Liver Transpl 2005;11:980-986. (Pubitemid 41122457)
20. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA 2005;293:1861-1867. (Pubitemid 40548182)
21. Pellis L, Franssen-van Hal NL, Burema J, Keijer J. The intraclass correlation coefficient applied for evaluation of data correction, labeling methods, and rectal biopsy sampling in DNA microarray experiments. Physiol Genomics 2003;16:99-106. (Pubitemid 38420024)
22. Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 2007;298:2028-2037.
23. Spannbauer MM, Oleszczuk A, Tannapfel A, Blüher M, Pietsch UC, Hengstler J, et al. Micro- and macrovesicular steatotic liver model for transplantation induced by ethanol and protein-deficient diet. Transplant Proc 2005;37:210-211. (Pubitemid 40459738)
24. Brandhagen D, Fidler J, Rosen C. Evaluation of the donor liver for living donor liver transplantation. Liver Transpl 2003;9:S16-S28. (Pubitemid 37309280)
25. Angelico M. Donor liver steatosis and graft selection for liver transplantation: a short review. Eur Rev Med Pharmacol Sci 2005;9:295-297. (Pubitemid 41387395)
26. Nakamuta M, Morizono S, Soejima Y, Yoshizumi T, Aishima S, Takasugi S, et al. Short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation. Transplantation 2005;80:608-612. (Pubitemid 41377747)
27. Verran D, Kusyk T, Painter D, Fisher J, Koorey D, Strasser S, et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl 2003;9:500-505. (Pubitemid 36621720)
28. Van Ness MM, Diehl AM. Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes? Ann Intern Med 1989;111:473-478.
29. Tran TT, Changsri C, Shackleton CR, Poordad FF, Nissen NN, Colquhoun S, et al. Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donors. J Gastroenterol Hepatol 2006;21:381-383.
30. Karcaaltincaba M, Akhan O. Imaging of hepatic steatosis and fatty sparing. Eur J Radiol 2007;61:33-43. (Pubitemid 46038027)
31. Perkins JD. Saying "yes" to obese living liver donors: short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation. Liver Transpl 2006;12:1012-1013.
32. Hwang S, Lee SG, Jang SJ, Cho SH, Kim KH, Ahn CS, et al. The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation. Liver Transpl 2004;10:726-727.
33. Guzzaloni G, Grugni G, Minocci A, Moro D, Morabito F. Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test. Int J Obes Relat Metab Disord 2000;24:772-776. (Pubitemid 30339276)
34. Bellentani S, Saccoccio G, Masutti F, Crocè LS, Brandi G, Sasso F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000;132:112-117.
35. Chitturi S, Farrell GC, Hashimoto E, Saibara T, Lau GK, Sollano JD. Non-alcoholic fatty liver disease in the Asia- Pacific region: definitions and overview of proposed guidelines. J Gastroenterol Hepatol 2007;22:778-787. (Pubitemid 46915352)
36. Chan HL, de Silva HJ, Leung NW, Lim SG, Farrell GC. How should we manage patients with non-alcoholic fatty liver disease in 2007. J Gastroenterol Hepatol 2007;22:801-808. (Pubitemid 46911037)
37. Roy Choudhury S, Knapp LA. A review of international and UK-based ethical guidelines for researchers conducting nontherapeutic genetic studies in developing countries. Eur J Hum Genet 2006;14:9-16.